AADI - Aadi Bioscience GAAP EPS of -$0.57 beats by $0.03 revenue of $5.9M beats by $0.42M
2023-05-10 08:32:03 ET
- Aadi Bioscience press release ( NASDAQ: AADI ): Q1 GAAP EPS of -$0.57 beats by $0.03 .
- Revenue of $5.9M (+155.4% Y/Y) beats by $0.42M .
- Cash, cash equivalents and short-term investments as of March 31, 2023 were $151.2 million as compared to $172.6 million as of December 31, 2022, which is expected to fund operations into 2025 based on current plans.
- Net loss for the three months ended March 31, 2023 was $15.2 million as compared to $13.9 million for the three months ended March 31, 2022.
For further details see:
Aadi Bioscience GAAP EPS of -$0.57 beats by $0.03, revenue of $5.9M beats by $0.42M